IPO registrations (S-1, F-1) · Registrants
Sunshine Biopharma Inc.
- SEC CIK
- 1402328 · filings on EDGAR ↗
- Former names
- Sunshine Biopharma, Inc (2009–2024); Mountain West Business Solutions, Inc (2007–2009); mountain west business solutions,inc (2007–2007); mountain state business solutions,inc (2007–2007)
- Registration
- Form S-1, first filed 2008-02-12, last 2026-10-02; 8 initial registrations, 7 amendments
- Outcome
- Final prospectus filed 2022-02-17; declared effective 2014-07-23; withdrawal requested 2008-02-14
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- CO
- Business address
- 333 LAS OLAS WAY, CU4 SUITE 433, Fort Lauderdale, FL 33301
- EIN
- 20-5566275
- Ticker
- SBFM, SBFMW (Nasdaq, Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- Sunshine Biopharma Inc. on the corporate pages
Offering terms
- Final price
- $4.25 per share (424B4 filed 2022-02-17, an initial public offering)
- Shares sold
- 1,882,353
- Gross proceeds
- $8,000,000 before underwriting discounts and any over-allotment option
- Listing
- OTC under the symbol SBFM
- Lead underwriters
- Aegis Capital (1,882,353 shares)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: Sunshine Biopharma Inc. Fuzzy (name and state)
- Form D issuer: Sunshine Biopharma, Inc EXACT (CIK (EXACT))
- SEC filer: Mountain West Business Solutions, Inc EXACT (CIK (EXACT))
Filings 37
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2008-02-12 | S-1/A | S-1/A (amendment) | Mountain West Business Solutions, Inc | 0001079974-08-000186 ↗ |
| 2008-02-14 | RW | RW (withdrawal request) | Mountain West Business Solutions, Inc | 0001079974-08-000199 ↗ |
| 2014-01-22 | RW | RW (withdrawal request) | Sunshine Biopharma, Inc | 0001354488-14-000284 ↗ |
| 2014-04-29 | RW | RW (withdrawal request) | Sunshine Biopharma, Inc | 0001354488-14-002116 ↗ |
| 2014-05-22 | S-1 | S-1 (registration) | Sunshine Biopharma, Inc | 0001354488-14-002936 ↗ |
| 2014-07-03 | S-1/A | S-1/A (amendment) | Sunshine Biopharma, Inc | 0001354488-14-003530 ↗ |
| 2014-07-23 | EFFECT | EFFECT (declared effective) | Sunshine Biopharma, Inc | 9999999995-14-002199 ↗ |
| 2018-10-09 | S-1 | S-1 (registration) | Sunshine Biopharma, Inc | 0001654954-18-010915 ↗ |
| 2018-10-31 | RW | RW (withdrawal request) | Sunshine Biopharma, Inc | 0001654954-18-011766 ↗ |
| 2021-09-09 | S-1 | S-1 (registration) | Sunshine Biopharma, Inc | 0001683168-21-004175 ↗ |
| 2022-01-24 | S-1/A | S-1/A (amendment) | Sunshine Biopharma, Inc | 0001683168-22-000418 ↗ |
| 2022-02-03 | S-1/A | S-1/A (amendment) | Sunshine Biopharma, Inc | 0001683168-22-000663 ↗ |
| 2022-02-09 | S-1/A | S-1/A (amendment) | Sunshine Biopharma, Inc | 0001683168-22-000809 ↗ |
| 2022-02-14 | S-1/A | S-1/A (amendment) | Sunshine Biopharma, Inc | 0001683168-22-000916 ↗ |
| 2022-02-14 | EFFECT | EFFECT (declared effective) | Sunshine Biopharma, Inc | 9999999995-22-000447 ↗ |
| 2022-02-17 | 424B4 | 424B4 (final prospectus) | Sunshine Biopharma, Inc | 0001683168-22-001075 ↗ |
| 2022-04-08 | EFFECT | EFFECT (declared effective) | Sunshine Biopharma, Inc | 9999999995-22-000900 ↗ |
| 2022-05-20 | EFFECT | EFFECT (declared effective) | Sunshine Biopharma, Inc | 9999999995-22-001551 ↗ |
| 2023-06-05 | EFFECT | EFFECT (declared effective) | Sunshine Biopharma, Inc | 9999999995-23-001634 ↗ |
| 2024-02-01 | S-1 | S-1 (registration) | Sunshine Biopharma, Inc | 0001683168-24-000610 ↗ |
| 2024-02-09 | S-1/A | S-1/A (amendment) | Sunshine Biopharma, Inc | 0001683168-24-000849 ↗ |
| 2024-02-12 | EFFECT | EFFECT (declared effective) | Sunshine Biopharma, Inc | 9999999995-24-000394 ↗ |
| 2024-02-14 | 424B4 | 424B4 (final prospectus) | Sunshine Biopharma, Inc | 0001683168-24-000953 ↗ |
| 2024-11-08 | EFFECT | EFFECT (declared effective) | Sunshine Biopharma Inc. | 9999999995-24-003412 ↗ |
| 2024-11-12 | 424B4 | 424B4 (final prospectus) | Sunshine Biopharma Inc. | 0001683168-24-007865 ↗ |
| 2025-01-15 | EFFECT | EFFECT (declared effective) | Sunshine Biopharma Inc. | 9999999995-25-000122 ↗ |
| 2025-08-05 | S-1 | S-1 (registration) | Sunshine Biopharma Inc. | 0001683168-25-005644 ↗ |
| 2025-08-12 | RW | RW (withdrawal request) | Sunshine Biopharma Inc. | 0001683168-25-005976 ↗ |
| 2025-08-12 | EFFECT | EFFECT (declared effective) | Sunshine Biopharma Inc. | 9999999995-25-002587 ↗ |
| 2026-05-12 | S-1 | S-1 (registration) | Sunshine Biopharma Inc. | 0001683168-26-003726 ↗ |
| 2026-05-18 | EFFECT | EFFECT (declared effective) | Sunshine Biopharma Inc. | 9999999995-26-001691 ↗ |
| 2026-05-19 | 424B4 | 424B4 (final prospectus) | Sunshine Biopharma Inc. | 0001683168-26-004098 ↗ |
| 2026-08-28 | S-1 | S-1 (registration) | Sunshine Biopharma Inc. | 0001683168-26-006779 ↗ |
| 2026-09-08 | EFFECT | EFFECT (declared effective) | Sunshine Biopharma Inc. | 9999999995-26-002914 ↗ |
| 2026-10-02 | S-1 | S-1 (registration) | Sunshine Biopharma Inc. | 0001683168-26-007581 ↗ |
| 2026-10-07 | EFFECT | EFFECT (declared effective) | Sunshine Biopharma Inc. | 9999999995-26-003179 ↗ |
| 2026-10-09 | 424B4 | 424B4 (final prospectus) | Sunshine Biopharma Inc. | 0001683168-26-007757 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2022-02-14 | S-1/A | registration statement | 1,020,408 | - | OTC SBFM | 1 | primary document; shares headline, cover names 1 | document ↗ | ||
| 2022-02-17 | 424B4 | final prospectus | $4.25 | 1,882,353 | $8,000,000 | OTC SBFM | 1 | primary document; price sentence, shares headline, proceeds table, underwriting table 1, cover names 1 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Di Turi Michele | Director,Officer | Chief Operating Officer | 2 | 2009–2015 | |
| Sebaaly Camille | Director,Officer; Director,Officer,TenPercentOwner; Officer | CFO and Secretary; CFO/Secretary; Secretary | 12 | 2009–2022 | |
| Slilaty Steve N. | Director,Officer; Director,Officer,TenPercentOwner | CEO and President; Chief Executive Officer | 19 | 2009–2024 | |
| MERZOUKI ABDERRAZZAK | Director,Officer | Chief Operating Officer | 15 | 2015–2021 | |
| Advanomics Corp | TenPercentOwner | 2 | 2016 | ||
| TELSEY ANDREW I | Director | 1 | 2021 | ||
| Kish James Daniel | Director | 1 | 2021 | ||
| Kiderchah Rabi | Director | 1 | 2021 | ||
| Keller Andrew Mark | Director | 1 | 2022 | ||
| NATAN DAVID | Director | 3 | 2022–2026 | ||
| Chamoun Malek | TenPercentOwner | 1 | 2022 | ||
| Beaudoin Marc | Officer | Chief Operating Officer | 1 | 2024 | |
| Roy Michel | Officer | Chief Commercial Officer | 1 | 2025 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2023-05-17 | Sunshine Biopharma, Inc | Pharmaceuticals | $4,996,497 | $4,996,497 | 1 | 1 |
| 2022-04-29 | Sunshine Biopharma, Inc | Pharmaceuticals | $19,497,618 | $19,497,618 | 9 | 1 |
| 2022-03-18 | Sunshine Biopharma, Inc | Pharmaceuticals | $7,998,699 | $7,998,699 | 9 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | Sunshine Biopharma Inc. | FL | State business registries | name and state |
| Form D issuer | Sunshine Biopharma, Inc | Form D private offerings | CIK (EXACT) | |
| SEC filer | Sunshine Biopharma Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | Sunshine Biopharma Inc. | FL | Trademarks (USPTO) | name and state |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, FL first:
- SANO CORP FL
- CTT PHARMACEUTICAL HOLDINGS, INC. FL
- Inhibitor Therapeutics, Inc. FL
- GENEREX BIOTECHNOLOGY CORP FL
- BIOMOLECULAR LIFE HOLDINGS, INC. FL
- Alaunos Therapeutics, Inc. FL
- ORAGENICS INC FL
- Polomar Health Services, Inc. FL
- ACCENTIA BIOPHARMACEUTICALS INC FL
- NOMAD POWER SOLUTIONS, INC. FL
In other datasets, the same topic (Health) in FL:
- Nonprofit: 414 WELLWOMEN INC (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health